SLAMF7 and Miyoshi myopathy: In the t(14;16) comparison, SLAMF7, which encodes a cell surface immunotherapeutic antigen that can be targeted in MM [27] and immune cells [28], underwent a mutually exclusive exon event generating transcripts SLAMF7-204 and SLAMF7-201 (Fig. 2D, E).